(Q42451715)

31 October 2017

The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor (English)

1 reference

31 October 2017

The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor (English)

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

6

Brian K Kobilka

1 reference

31 October 2017

Khalid Chakir

1

1 reference

31 October 2017

Yang Xiang

2

1 reference

31 October 2017

Dongmei Yang

3

1 reference

31 October 2017

Sheng-Jun Zhang

4

1 reference

31 October 2017

Heping Cheng

5

1 reference

31 October 2017

Rui-Ping Xiao

7

1 reference

31 October 2017

Brian K. Kobilka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14573753

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14573753

24 March 2024

publication date

1 November 2003

1 reference

full work available at URL

31 October 2017

https://syndication.highwire.org/content/doi/10.1124/mol.64.5.1048

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

published in

1 reference

31 October 2017

64

1 reference

31 October 2017

5

1 reference

31 October 2017

1048-1058

1 reference

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy

31 October 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Aldosterone induces ras methylation in A6 epithelia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Constitutively active mutants of the beta1-adrenergic receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Constitutive activity of glucagon receptor mutants

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

What type of beta-blocker should be used to treat chronic heart failure?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Inhibition of spontaneous beta 2-adrenergic activation rescues beta 1-adrenergic contractile response in cardiomyocytes overexpressing beta 2-adrenoceptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

The effect of Gi-protein inactivation on basal, and beta(1)- and beta(2)AR-stimulated contraction of myocytes from transgenic mice overexpressing the beta(2)-adrenoceptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Role of the third intracellular loop for the activation of gonadotropin receptors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Seven-transmembrane-spanning receptors and heart function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Spontaneous beta(2)-adrenergic signaling fails to modulate L-type Ca(2+) current in mouse ventricular myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Spontaneous activation of beta(2)- but not beta(1)-adrenoceptors expressed in cardiac myocytes from beta(1)beta(2) double knockout mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1124/MOL.64.5.1048

5

45

490

1994

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

6

50

662

1996

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

American Journal of Physiology

24 March 2024

10

271

H630

1996

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

12

60

712

2001

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

19

41

889

1992

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

22

49

1021

1996

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

24

54

616

1998

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

42

60

629

2001

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

American Journal of Physiology

24 March 2024

53

258

H574

1990

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

Science's STKE : signal transduction knowledge environment

24 March 2024

61

104

RE15

2001

1 reference

https://api.crossref.org/works/10.1124/MOL.64.5.1048

24 March 2024

Identifiers

1 reference

31 October 2017

1 reference